BioCentury
ARTICLE | Company News

Progen Biotechnik GmbH, University Hospital sales and marketing update

June 10, 1996 7:00 AM UTC

Progen began selling a peptide ELISA test developed in conjunction with University Hospital for clinical research in vascular medicine. The test detects auto-antibodies specific to the C-terminal 27 amino acids of calpastatin, an inhibitor of the proteinase calpain. ...